DZ Bank’s Psychemedics Corporation PMD Stock Holding History

DZ Bank’s Portfolio PMD Stock Details PMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-4,385	Closed	-$109K	–	964
2017 Q2	$109K	Buy	+4,385	New	+$92.2K	﹤0.01%	784

Other funds holding PMD

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIC

Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

DZ Bank's PMD Position: Q3 2017 in Review

DZ Bank sold out of Psychemedics Corporation (PMD) in Q3 2017, closing a stake of 4,385 shares — an estimated $109K sold.

DZ Bank first reported a position in PMD in Q2 2017 and held it in 1 quarter. The position peaked at $109K in Q2 2017. 51 funds tracked by Wall St. Rank hold PMD as of Q3 2017.

DZ Bank reported no remaining Psychemedics Corporation position as of Q3 2017 after selling out during the quarter.
DZ Bank sold 4,385 Psychemedics Corporation shares in Q3 2017, an estimated $109K.
DZ Bank first reported a position in Psychemedics Corporation in Q2 2017 and held it in 1 quarter.
DZ Bank's Psychemedics Corporation position peaked at $109K in Q2 2017.
51 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q3 2017.

Based on DZ Bank's 13F filing for Q3 2017, filed 14 Nov 2017.